Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

OBIO

OBIO News

Newswire

10:25

Orchestra BioMed shares rise 12.96% intraday after CEO buys 5,000 shares and company secures $147M in funding for cardiovascular trials.

17:07

Orchestra BioMed Director Hochman Buys 5,000 Shares at $4.07 Per Share

09:08

Chardan Capital Raises PT to $20 for Orchestra BioMed, Maintains Buy Rating

09:08

Orchestra BioMed:Chardan Capital maintains Buy, PT raised to $20 from $20.

08:36

Orchestra BioMed Q3 2025 Corporate Update Conference Call Highlights

View More

About OBIO

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More